Association between Heat Shock Protein-60 and Development of Atrial Fibrillation: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
Background During atrial fibrillation (AF), a high rate of myocyte activation causes cellular stress and initiates the process of atrial remodeling, which further promotes persistence of AF. Although heat shock proteins (HSPs) have been shown to prevent atrial remodeling and suppress the occurrence...
Gespeichert in:
Veröffentlicht in: | Pacing and clinical electrophysiology 2016-12, Vol.39 (12), p.1373-1378 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
During atrial fibrillation (AF), a high rate of myocyte activation causes cellular stress and initiates the process of atrial remodeling, which further promotes persistence of AF. Although heat shock proteins (HSPs) have been shown to prevent atrial remodeling and suppress the occurrence of AF in cellular and animal experimental models, increased levels of HSP‐60 have been observed in patients with postoperative AF, likely reflecting a response to cellular stress. To better understand the role of HSP‐60 in relation to AF, we examined the association of HSP‐60 levels in relation to the future development of AF in the Multi‐Ethnic Study of Atherosclerosis (MESA).
Methods
MESA is a cohort study that recruited 6,814 participants aged 45–84 years and free of known cardiovascular disease at baseline (2000–2002) from six field centers. We investigated 983 participants, selected at random from the total cohort, who had HSP‐60 measured and were free of AF at baseline. We tested the association of HSP‐60 levels with the incidence of AF using multivariate Cox models after adjustment for demographics, clinical characteristics, and biomarkers.
Results
During an average of 10.6 years of follow‐up, 77 participants developed AF. We did not observe a significant association between the log‐transformed HSP‐60 levels and development of AF on either unadjusted or multivariate analysis (adjusted hazard ratio: 1.02 per unit difference on natural log scale, 95% confidence interval: 0.77–1.34 ln (ng/mL).
Conclusion
Contrary to the findings from the preclinical studies, which demonstrated an important role of HSP‐60 in the pathogenesis of AF, we did not observe a significant association between HSP‐60 and occurrence of AF. |
---|---|
ISSN: | 0147-8389 1540-8159 |
DOI: | 10.1111/pace.12969 |